Neriderm Cream

/ Perrigo

Adults: Initially, Neriderm should be applied thinly twice daily. When the
condition improves or when longer periods of treatment are required one
application daily is appropriate.
Long-term continuous therapy with topical corticosteroids should be avoided, with a usual maximum duration of 4 weeks. If used on the face, courses should be limited to 5 days and occlusion should not be used.
Children 1-4years of age: Neriderm should be applied thinly twice daily. It should be used with great care, for short periods and generally only on the advice of a doctor specialising in dermatology. Courses should be limited to 5 days and occlusion should not be used.
Children 5 years of age and over: Initially, Neriderm should be applied thinly
twice daily. When the condition improves one application daily is appropriate.
Courses should be limited to 1-2 weeks. If used on the face, courses should be
limited to 5 days and occlusion should not be used.
Neriderm should not be used in children under 1 year of age.
Elderly: Natural thinning of the skin occurs in the elderly. No special precautions are required, however, when Neriderm is used in this group of patients.
Occlusive dressings: An occlusive dressing may be called for in unusually refractory cases and usually under specialist supervision. If an infection develops under the dressing, occlusive treatment must be terminated.
Neriderm Cream is suitable for weeping skin conditions. Neriderm Cream has a
high water and low fat content. In weeping skin diseases it allows secretions to
drain away, thus providing for rapid reduction of swelling and drying up of the
skin. Neriderm Cream is also suitable for application to moist, exposed and hairy areas of the body. Neriderm Ointment is suitable in very dry skin conditions which need an anhydrous fatty base. The occlusive effect of the Neriderm Ointment base promotes the healing process.
If the skin dries out too much under protracted use of Neriderm Cream, the patient should be switched to a form which contains more fat (Neriderm Ointment).

Corticosteroid responsive dermatoses where no infection present.

Tuberculous or syphilitic processes in the area to be treated, virus diseases. First trimester of pregnancy. Applications to large areas of the body or for prolonged periods must be avoided.

Do not apply to the face. Pregnancy and lactation: It is not known whether topical application may result in sufficient systemic absorption to produce detectable quantities in breast milk. Nevertheless, caution should be exercised when topical corticosteroids are applied to a nursing woman. Pediatrics: Babies and children up to the age of 4 years should not be treated. In general, application to children should be limited to the least amount compatible with an effective therapeutic regimen. Additional, specific therapy is required in bacterially infected skin diseases and/or fungus infections. If sensitization occurs, discontinue use. Patients with electrolyte imbalance, gastrointestinal disturbances, diabetes, myopathy, cataract, renal or hepatic impairment, osteoporosis and hemorrhage. Occlusive dressings: After application, the area under treatment should be covered with a plastic foil which should then be fixed firmly around the healthy skin by means of adhesive plaster. The dressing should not be kept in place for longer than 24 hours.

Irritation and itching, dryness of the skin, rash and redness, sense of heat and tingling. When applied to large areas of the body (10% and more) and for long periods of time (more than 10 days): Atrophy of the skin, telangiectasia, striae, acneiform changes of the skin, perioral dermatitis, increased growth of body hair and systemic effects of the corticoid due to absorption, In rare cases allergic skin reactions may occur.

N/A